ClinicalTrials.gg
Active, not recruitingNCT04378049RoboKneesUpdated May 9, 2025

Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement

An interventional study of Total knee arthroplasty and Robot-assisted partial knee arthroplasty in Knee Osteoarthritis, sponsored by McMaster University. Active, not recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-09.

Sponsored by McMaster University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Osteoarthritis, Knee by McMaster University — 3 open to participants now, 4 under way, none of them phase 3. Osteoarthritis, Knee · McMaster University.

Planned enrollment
5th of 14
64 · median 40
Started
2020
the only one that year
No phase
12 of 14
3 open now
Registered
8th of 14
by date

Among the 14 studies in Osteoarthritis, Knee by McMaster University, this one is the 5th largest by planned enrollment, is the only one that started in 2020, is one of 12 with no phase, and was the 8th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

3 of the 14 studies in Osteoarthritis, Knee by McMaster University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Osteoarthritis, Knee by McMaster University, or all of them as a file.
02

Study summary

This is a pilot randomized trial to assess the feasibility of a definitive trial to determine the effect of robot-assisted partial knee replacements versus standard total knee replacements.

Read the detailed description

Knee osteoarthritis (OA) pain is an important source of morbidity and cost to the health care system. Over 60,000 knee replacement surgeries are performed in Canada every year, making it the second most common surgery. Our institution (St. Joseph's Healthcare Hamilton) is the first hospital in Canada to purchase a Mako RIO orthopaedic robot to assist with performing knee replacements. The knee is divided into three compartments, and one, two, or all three compartments can become arthritic. Over 90% of patients with end-stage knee OA receive a total knee replacement (also known as total knee arthroplasty or TKA) even if they have one or two healthy knee compartments. Partial knee replacements are an option for these patients but these procedures are very technically demanding and associated with a higher risk of implant failure. For this reason, few surgeons are experts at partial knee replacements. We believe that we can use robotic technology to make it easier for surgeons to perform partial replacements more accurately, thereby increasing the quality and survivorship of partial knee replacements. This may lead to better patient-important outcomes like return to activity, pain, and satisfaction, and eventually better access to high-quality partial knee replacements for Canadians. This will be the first study to evaluate total knee replacements (standard care) versus robot-assisted partial knee replacements, and could lead to greater uptake of robotic technology in orthopaedics and a shift toward anatomy-sparing partial knee replacements.

03

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Total knee arthroplasty
  • Unicompartmental knee arthroplasty
  • Robot-assisted surgery
  • Pilot randomized controlled trial
  • Bicompartmental knee arthroplasty
  • Mako partial knee
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (18+)
  • Unicompartmental knee OA with or without concomitant patellofemoral OA, requiring surgical treatment
  • Two study surgeons independently agree that the patient is eligible for either treatment group

Exclusion criteria

Exclusion criteria

  • Inability to provide (e.g. cognitive disability, language barrier)
  • Revision knee surgery
  • Simultaneous bilateral knee surgery
  • Previous major knee surgery or trauma
  • The robot or required components are unavailable (e.g. technical difficulties, robot-specific disposables out of stock)
  • A CT scan cannot be obtained prior to surgery
  • Patient does not wish to participate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Standard total knee arthroplasty

    Participants who are randomized to the control group will undergo TKA according to local standard of care. The choice of implant and use of bone cement will be recorded but left to the surgeon's discretion according to their standard practice.

    Procedure: Total knee arthroplasty

  • Experimental
    Robot-assisted partial knee arthroplasty

    Participants with isolated medial or isolated lateral compartment OA who are randomized to the intervention group and have one affected knee compartment will receive a robot-assisted unicompartmental knee arthroplasty (UKA). If the patient has medial or lateral OA plus patellofemoral OA they will receive a bicompartmental knee arthroplasty (BiKA) consisting of a two simultaneous UKAs. The partial knee replacement procedures will be performed using the Mako RIO robotic arm (Stryker) according to the manufacturer's instructions. The choice of implant and use of bone cement will be recorded but will be left to the surgeon's discretion. Surgeons will resurface the patella if the patellar cartilage meets Outerbridge grade 3 or 4 criteria

    Procedure: Robot-assisted partial knee arthroplasty

Interventions

  • ProcedureTotal knee arthroplasty

    Surgeon will perform a total knee arthroplasty procedure according to local standard of care

    Also known as: Total knee replacement

  • ProcedureRobot-assisted partial knee arthroplasty

    Surgeon will perform a robot-assisted unicompartmental or bicompartmental knee arthroplasty procedure

    Also known as: MakoPlasty

06

What researchers measure

Primary outcomes

  1. Feasibility- Recruitment

    The number of patients recruited during a 12 month period

    Time frame: 12 months

  2. Feasibility- Participant retention

    Number of patients completing the study

    Time frame: 12 months

  3. Feasibility- Treatment compliance

    The number of crossovers during a 12 month period

    Time frame: 12 months

Secondary outcomes

  1. Return to function questionnaire

    We will use the 5-item Return To Function (RTF) questionnaire to determine when a trial participant returns to work, leisure, and activities around the home after an injury or surgery (measured as time to return to unrestricted activities).

    Time frame: 12 months post-surgery

  2. Oxford knee score

    We will measure knee function using the Oxford Knee Score (OKS), which is a validated and well-used 12 item questionnaire used to measure knee function when performing daily activities after total knee replacement surgery. The OKS is scored on a 0-48 scale with higher scores representing a better outcome.

    Time frame: 12 months post-surgery

  3. Forgotten joint score

    We will use the Forgotten Joint Score (FJS-Knee) to measure how natural the replaced knee feels. The FJS-Knee is a 12 item questionnaire that aims to assess both function and feeling by asking about patients' awareness of their artificial knee while doing various daily activities. The FJS is scored on a 0-100 scale with higher scores representing a better outcome.

    Time frame: 12 months post-surgery

  4. Gait walking mechanics analysis

    Overground walking kinematic gait analysis will be performed in the clinic environment using a ten-camera optoelectronic motion capture system. Primary gait outcomes will include the knee joint flexion and adduction angle magnitudes and range during the stance phase of gait. Secondary gait outcomes will include stride characteristics as defined above, knee transverse rotation during stance, knee flexion during swing, hip and ankle range of motion and peak magnitudes during stance.

    Time frame: 12 months post-surgery

  5. Quality of life- EQ-5D

    We will use the Euro-Qol 5 Dimensions (EQ-5D) questionnaire, a widely used and well-validated quality of life tool, to measure participant quality of life. The EQ-5D is a comprehensive, 5-item compact health status classification and health state preference questionnaire.

    Time frame: 12 months post-surgery

  6. Persistent post-surgical pain (PPSP)

    We will use a modified version of the WHO's definition of PPSP, to include a minimum threshold of pain severity: 1. Pain that began after surgery or a tissue trauma; 2. Pain is in an area of preceding surgery or tissue trauma; 3. Pain has persisted for at least three months after surgery; and 4. The pain is not better explained by an infection, malignancy, a pre-existing pain condition or any other alternative cause. 5. ≥4 out of 10 on the numeric rating scale (NRS) from the Brief Pain Inventory (BPI-SF) for "average pain over the last week". The scale ranges from 0 (no pain) to 10 (pain as bad as you can imagine)

    Time frame: 12 months post-surgery

  7. Patient global impression of change score

    We will use The Patient Global Impression of Change (PGIC) scale to assess patients' beliefs about the efficacy of treatment. The PGIC is one item and asks patients to rate the effectiveness of the treatment of interest on a 7-point ordinal scale ranging from "very much improved" to "very much worse

    Time frame: 12 months post-surgery

  8. Healthcare resource use (for cost-effectiveness)

    We will collect healthcare resource utilization information (e.g. hospitalization, physician visits) and information on productivity (e.g. time missed from work) to assist with health economic analyses.

    Time frame: 12 months post-surgery

  9. Rage of motion (ROM)

    We will measure knee ROM using a goniometer at in-clinic visits according to standard practice

    Time frame: 6 weeks post-surgery

  10. Knee alignment

    We will measure mechanical alignment on pre-operative and post-operative weightbearing x-rays

    Time frame: Post-surgery

  11. Adverse events

    We will collect all serious adverse events and surgery-related non-serious adverse events throughout the trial for safety monitoring purposes

    Time frame: 12 months post-surgery

  12. Short-term implant survival

    We will report the number of revision surgeries within the study period including cases of periprosthetic joint infection, aseptic loosening, instability, poly wear, intractable pain, periprosthetic fracture etc.

    Time frame: 12 months post-surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — We will share data upon reasonable request for non-commercial purposes. This may require an institutional data-sharing agreement.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: Upon study completion.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2020 (actual). Primary completion is estimated for Dec 2026, 73 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 73 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2020
First posted
May 7, 2020
StartActual
Nov 23, 2020
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
May 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04378049
Collaborators
St. Joseph's Healthcare Hamilton, Hamilton Academic Health Sciences Organization, Canadian Institutes of Health Research (CIHR)
Responsible party
Sponsor
First posted
May 7, 2020
Start date
Nov 23, 2020
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 9, 2025

Study contacts

Anthony Adili, MD, P.Eng, FRCSC
principal investigator · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion